Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04173507 |
|---|---|
| Brief Title: | Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial) |
| First Submitted : | November 20, 2019 |
| First Submitted that Met QC Criteria : | November 20, 2019 |
| First Posted : | November 22, 2019 |
| Results First Submitted : | October 18, 2022 |
| Results First Posted with QC Comments : | November 16, 2022 |
| Results First Submitted that Met QC Criteria : | December 14, 2022 |
| Results First Posted : | January 9, 2023 |
| Last Update Submitted that Met QC Criteria : | December 14, 2022 |
| Last Update Posted : | January 9, 2023 |